Emergence of resistance to novel β-lactam/β-lactamase inhibitor combinations in KPC-producing Klebsiella pneumoniae: clinical and genomic insights from consecutive bloodstream infections

Resistance to novel BL/BLICs among KPC-producing K. pneumoniae is emerging in Italian hospitals, largely mediated by bla<sub>KPC</sub> variants and porin defects under selective antibiotic pressure. While ATM/AVI, MEM/VAB and IMP/REL remain highly active, resistance to CAZ/AVI is increasingly frequent. Continuous genomic surveillance and optimised antimicrobial stewardship are essential to preserve the efficacy of these last-line agents.

Authors

Institutions

Publication Details

Journal
Infection
Published
2025-12-23
DOI
https://doi.org/10.1007/s15010-025-02716-4
Citations
1
Primary Topic
Antibiotic Resistance in Bacteria
Type
article
Field-Weighted Citation Impact
0.59
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Emergence of resistance to novel β-lactam/β-lactamase inhibitor combinations in KPC-producing Klebsiella pneumoniae: clinical and genomic insights from consecutive bloodstream infections

Gabriele Bianco, Luisa Guarrasi, Lisa Pastrone, Paolo Gaibani et al.
1 citations
Infection
Antibiotic Resistance in Bacteria
0.59
article

Emergence of resistance to novel β-lactam/β-lactamase inhibitor combinations in KPC-producing Klebsiella pneumoniae: clinical and genomic insights from consecutive bloodstream infections

Gabriele Bianco, Luisa Guarrasi, Lisa Pastrone, Paolo Gaibani, Guido Ricciardelli, Sara Comini, C. Costa, Matteo Boattini, Roberto Casale, Rossana Cavallo
article en
1 citations

Abstract

Resistance to novel BL/BLICs among KPC-producing K. pneumoniae is emerging in Italian hospitals, largely mediated by bla<sub>KPC</sub> variants and porin defects under selective antibiotic pressure. While ATM/AVI, MEM/VAB and IMP/REL remain highly active, resistance to CAZ/AVI is increasingly frequent. Continuous genomic surveillance and optimised antimicrobial stewardship are essential to preserve the efficacy of these last-line agents.

InfectionVol. 54(2)
University of Verona (IT), University of Salento (IT), Azienda Ospedaliera Citta' della Salute e della Scienza di Torino (IT), Azienda Ospedaliera Universitaria Integrata Verona (IT), Ospedale Vito Fazzi (IT), Carlo Forlanini Hospital (IT), University of Turin (IT)
Openalex Percentile: Top 26%
Antibiotic Resistance in Bacteria
0.59
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.